MedTrace Logo

Study Looking at End Expiratory Pressure for Altitude Illness Decrease (SLEEP-AID)

NCT01842906 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 219

Last updated 2018-12-13

Study results available
· View outcomes & findings →

Summary

The study is examining if an over-the-counter device (Theravent) worn while sleeping can reduce acute mountain sickness upon awakening in a high altitude trekking population.

Conditions

  • Acute Mountain Sickness

Interventions

DEVICE

Theravent

nasal EPAP device

DEVICE

Control

Sham device without EPAP

Sponsors & Collaborators

Principal Investigators

  • Grant S Lipman, MD · Stanford University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-10-31
Primary Completion
2013-12-31
Completion
2014-10-31

Countries

  • Nepal

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01842906 on ClinicalTrials.gov